Plumbline Life Sciences, Inc. (XKON:222670)
South Korea
· Delayed Price · Currency is KRW
7,800.00
+110.00 (1.43%)
At close: Aug 13, 2025, 3:30 PM KST
Plumbline Life Sciences Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| FY 2014 |
| Dec '14 Dec 31, 2014 |
| Selling, General & Admin | 348.96 |
| Operating Expenses | 590.62 |
| Operating Income | -590.62 |
| Interest Expense | -42.12 |
| Interest & Investment Income | 0.24 |
| Currency Exchange Gain (Loss) | -140.48 |
| Other Non Operating Income (Expenses) | -1.01 |
| Pretax Income | -773.99 |
| Net Income | -773.99 |
| Net Income to Common | -773.99 |
| Shares Outstanding (Basic) | 1 |
| Shares Outstanding (Diluted) | 1 |
| EPS (Basic) | -771.00 |
| EPS (Diluted) | -771.00 |
| Free Cash Flow | -338.61 |
| Free Cash Flow Per Share | -337.30 |
| EBITDA | -348.84 |
| D&A For EBITDA | 241.78 |
| EBIT | -590.62 |
Source: S&P Global Market Intelligence. Standard template.
Financial Sources.